FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046196221> ?p ?o ?g. }

• W2046196221 endingPage "141" @default.
• W2046196221 startingPage "134" @default.
• W2046196221 abstract "Toxoplasma gondii is an obligate intracellular apicomplexan parasite that can infect a wide range of warm-blooded animals including humans. In humans and other intermediate hosts, toxoplasma develops into chronic infection that cannot be eliminated by host's immune response or by currently used drugs. In most cases, chronic infections are largely asymptomatic unless the host becomes immune compromised. Thus, toxoplasma is a global health problem and the situation has become more precarious due to the advent of HIV infections and poor toleration of drugs used to treat toxoplasma infection, having severe side effects and also resistance have been developed to the current generation of drugs. The emergence of these drug resistant varieties of T. gondii has led to a search for novel drug targets. We have performed a comparative analysis of metabolic pathways of the host Homo sapiens and the pathogen T. gondii. The enzymes in the unique pathways of T. gondii, which do not show similarity to any protein from the host, represent attractive potential drug targets. We have listed out 11 such potential drug targets which are playing some important work in more than one pathway. Out of these, one important target is Glutamate dehydrogenase enzyme; it plays crucial part in oxidation reduction, metabolic process and amino acid metabolic process. As this is also present in the targets of tropical diseases of TDR (Tropical disease related Drug) target database and no PDB and MODBASE 3D structural model is available, homology models for Glutamate dehydrogenase enzyme were generated using MODELLER9v6. The model was further explored for the molecular dynamics simulation study with GROMACS, virtual screening and docking studies with suitable inhibitors against the NCI diversity subset molecules from ZINC database, by using AutoDock-Vina. The best ten docking solutions were selected (ZINC01690699, ZINC17465979, ZINC17465983, ZINC18141294_03, ZINC05462670, ZINC01572309, ZINC18055497_01, ZINC18141294, ZINC05462674 and ZINC13152284_01). Further the Complexes were analyzed through LIGPLOT. On the basis of Complex scoring and binding ability it is deciphered that these NCI diversity set II compounds, specifically ZINC01690699 (as it has minimum energy score and one of the highest number of interactions with the active site residue), could be promising inhibitors for T. gondii using Glutamate dehydrogenase as Drug target." @default.
• W2046196221 created "2016-06-24" @default.
• W2046196221 creator A5002213321 @default.
• W2046196221 creator A5011971205 @default.
• W2046196221 creator A5027090470 @default.
• W2046196221 creator A5036643295 @default.
• W2046196221 creator A5040682203 @default.
• W2046196221 creator A5048880303 @default.
• W2046196221 creator A5077464786 @default.
• W2046196221 creator A5082094095 @default.
• W2046196221 date "2012-02-03" @default.
• W2046196221 modified "2023-10-08" @default.
• W2046196221 title "Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach" @default.
• W2046196221 cites W1608392597 @default.
• W2046196221 cites W1818833536 @default.
• W2046196221 cites W1980548213 @default.
• W2046196221 cites W1982640534 @default.
• W2046196221 cites W1986861936 @default.
• W2046196221 cites W1992104047 @default.
• W2046196221 cites W2031417483 @default.
• W2046196221 cites W2051429365 @default.
• W2046196221 cites W2060572006 @default.
• W2046196221 cites W2078682062 @default.
• W2046196221 cites W2097659338 @default.
• W2046196221 cites W2106951092 @default.
• W2046196221 cites W2108422125 @default.
• W2046196221 cites W2136308226 @default.
• W2046196221 cites W2153872971 @default.
• W2046196221 cites W2164997719 @default.
• W2046196221 cites W2791126481 @default.
• W2046196221 doi "https://doi.org/10.6026/97320630008134" @default.
• W2046196221 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3283885" @default.
• W2046196221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22368385" @default.
• W2046196221 hasPublicationYear "2012" @default.
• W2046196221 type Work @default.
• W2046196221 sameAs 2046196221 @default.
• W2046196221 citedByCount "17" @default.
• W2046196221 countsByYear W20461962212012 @default.
• W2046196221 countsByYear W20461962212013 @default.
• W2046196221 countsByYear W20461962212014 @default.
• W2046196221 countsByYear W20461962212015 @default.
• W2046196221 countsByYear W20461962212016 @default.
• W2046196221 countsByYear W20461962212017 @default.
• W2046196221 countsByYear W20461962212018 @default.
• W2046196221 countsByYear W20461962212020 @default.
• W2046196221 countsByYear W20461962212022 @default.
• W2046196221 crossrefType "journal-article" @default.
• W2046196221 hasAuthorship W2046196221A5002213321 @default.
• W2046196221 hasAuthorship W2046196221A5011971205 @default.
• W2046196221 hasAuthorship W2046196221A5027090470 @default.
• W2046196221 hasAuthorship W2046196221A5036643295 @default.
• W2046196221 hasAuthorship W2046196221A5040682203 @default.
• W2046196221 hasAuthorship W2046196221A5048880303 @default.
• W2046196221 hasAuthorship W2046196221A5077464786 @default.
• W2046196221 hasAuthorship W2046196221A5082094095 @default.
• W2046196221 hasBestOaLocation W20461962211 @default.
• W2046196221 hasConcept C104317684 @default.
• W2046196221 hasConcept C153726182 @default.
• W2046196221 hasConcept C159047783 @default.
• W2046196221 hasConcept C159654299 @default.
• W2046196221 hasConcept C18903297 @default.
• W2046196221 hasConcept C192989942 @default.
• W2046196221 hasConcept C24990904 @default.
• W2046196221 hasConcept C2776460866 @default.
• W2046196221 hasConcept C2778062946 @default.
• W2046196221 hasConcept C2778128430 @default.
• W2046196221 hasConcept C2780035454 @default.
• W2046196221 hasConcept C54355233 @default.
• W2046196221 hasConcept C60644358 @default.
• W2046196221 hasConcept C64903051 @default.
• W2046196221 hasConcept C70721500 @default.
• W2046196221 hasConcept C74187038 @default.
• W2046196221 hasConcept C86803240 @default.
• W2046196221 hasConcept C8891405 @default.
• W2046196221 hasConcept C89423630 @default.
• W2046196221 hasConcept C98274493 @default.
• W2046196221 hasConceptScore W2046196221C104317684 @default.
• W2046196221 hasConceptScore W2046196221C153726182 @default.
• W2046196221 hasConceptScore W2046196221C159047783 @default.
• W2046196221 hasConceptScore W2046196221C159654299 @default.
• W2046196221 hasConceptScore W2046196221C18903297 @default.
• W2046196221 hasConceptScore W2046196221C192989942 @default.
• W2046196221 hasConceptScore W2046196221C24990904 @default.
• W2046196221 hasConceptScore W2046196221C2776460866 @default.
• W2046196221 hasConceptScore W2046196221C2778062946 @default.
• W2046196221 hasConceptScore W2046196221C2778128430 @default.
• W2046196221 hasConceptScore W2046196221C2780035454 @default.
• W2046196221 hasConceptScore W2046196221C54355233 @default.
• W2046196221 hasConceptScore W2046196221C60644358 @default.
• W2046196221 hasConceptScore W2046196221C64903051 @default.
• W2046196221 hasConceptScore W2046196221C70721500 @default.
• W2046196221 hasConceptScore W2046196221C74187038 @default.
• W2046196221 hasConceptScore W2046196221C86803240 @default.
• W2046196221 hasConceptScore W2046196221C8891405 @default.
• W2046196221 hasConceptScore W2046196221C89423630 @default.
• W2046196221 hasConceptScore W2046196221C98274493 @default.
• W2046196221 hasIssue "3" @default.
• W2046196221 hasLocation W20461962211 @default.

• next